Egypt Cardiac Surgery Instruments Market Report 2022 to 2030

Egypt Cardiac Surgery Instruments Market Analysis

$ 3999

The Egypt Cardiac Surgery Instruments Market is expected to witness growth from $6 Mn in 2022 to $11 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Egypt, cardiac conditions like coronary artery disease and heart failure are extremely prevalent. The need for the instruments used in these procedures is growing as a consequence of the rise in cardiac surgeries. The market is segmented by type, application and by end user. Some key players in this market include JK Medirise, EGMED, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10EGMD004 CATEGORY: Medical Devices GEOGRAPHY: Egypt AUTHOR: Jigyasu Bhandari

Buy Now

Egypt Cardiac Surgery Instruments Healthcare Market Executive Analysis

The Egypt Cardiac Surgery Instruments Market size is at around $6 Mn in 2022 and is projected to reach $11 Mn in 2030, exhibiting a CAGR of 8.10% during the forecast period. The health industry received only 5.2% of Egypt's total budget, or 1.5% of GDP, until 2021. The budget's share of healthcare costs decreased, falling from 4.9% in 2019 to 4.2% in 2022, the lowest amount in the previous five years. Government spending on health hit a new high of 1.6% of GDP. Spending on public health has increased to 3% of the GDP in Egypt.

In Egypt, for the diagnosis and treatment of various cardiovascular conditions, the cardiac surgery instruments business offers a variety of instruments and equipment. Better patient outcomes and fewer complications can come from cardiac surgeries that are more exact and precise. Modern medical techniques and equipment enable this. Some tools for cardiac surgery are created for minimally invasive procedures, which can lessen the need for open heart surgery, shorten hospital stays, and hasten recovery periods. In terms of the operations they can perform and the variety of cardiac conditions they can address, surgeons now have more choices thanks to advancements in cardiac surgery instruments and technologies. Heart problems can be imaged and identified using cardiac surgery instruments like electrocardiography, echocardiography, and angiography. Instruments used in cardiothoracic surgery can be used to substitute or repair damaged heart valves. Some of these tools include annuloplasty bands, valve sizes, and prosthetic valves. In this process, blocked or damaged arteries are bypassed using cardiac surgery tools like bypass grafts, shunts, and vascular clamps. The placement of stents, heart-lung machine support, and heart transplants are all cardiovascular operations that use cardiac surgery tools.

Egypt Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

Coronary artery disease and heart failure are very common cardiac diseases in Egypt. Due to the increase in cardiac surgeries, there is a rising demand for the instruments used in cardiac surgeries. Egypt's healthcare system is expanding as more facilities, particularly in the private sector, are setting up clinics and hospitals. Equipment for cardiac surgery is now more necessary than ever because of the increase in cardiac procedures. In recent years, both the state and private sectors have contributed more to Egypt's rising healthcare costs. Healthcare providers' eagerness to invest money in top-of-the-line, cutting-edge equipment to improve patient outcomes, has created a favourable environment for makers of cardiac surgery instruments.

Market Restraints

In Egypt, accessing funds for investments in R&D, machinery, and technology may be difficult for Egyptian manufacturers. This might make it more difficult for them to make cutting-edge, excellent cardiac surgery tools. In Egypt, there is strong rivalry in the market for cardiac surgery instruments between local and foreign makers. This could place pressure on regional producers to create instruments of high quality at reasonable costs.

Competitive Landscape

Key Players

JK Medirise (EG)
EGMED (EG)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

In Egypt, healthcare policies, including those concerning medical devices and apparatus, are developed and carried out by the Ministry of Health and Population (MoHP). Instruments used in heart surgery must be registered, licensed, and regulated by the Central Administration for Pharmaceutical Affairs (CAPA). Standards for cardiac surgery tools are established and upheld by the Egyptian Organization for Standardization and Quality Control (EOS). The Egyptian Medical Devices Technology and Manufacturers Association (EMDTMA) is a trade group that advocates for medical device producers in Egypt, including those who produce tools used in heart surgery. The organization collaborates closely with the government to support the expansion of Egypt's medical device sector. The rules established by CAPA and EOS must be followed by producers in order for their products to be sold in Egypt for use in cardiac surgery. This entails registering and licensing their products, upholding safety and quality standards, and following labelling and packing specifications.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Egypt market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.